iRegene Therapeutics

China · 6 Employees
We research and develop proprietary chemically-derived allogeneic cell therapy for degenerative diseases like Parkinson's Disease, Retinal Degenerative Diseases, Ischemic Stroke, etc. Our leading pipeline NouvNeu001 (Parkinson's Disease) is scheduled to initiate Phase I clinical trial in 2023 H1. We are a passionate team committed to developing first-in-class therapies for patients suffering from major incurable diseases. Making fast-acting and disease-reversing therapies accessible to patients in the greatest extent possible is our priority.

概述

国家 China
成立时间 2017
总部 Wuhan, Hubei
电话号码 +86027-65522933
网站 http://www.iregene.com
LinkedIn http://www.linkedin.com/company/iregene-therapeutics
Twitter
Facebook
员工数 6
行业 research,
简介 iRegene Therapeutics focuses on new generation of chemical defined cell therapy and aims to play an essential role in curing “incurable”diseases, such as degenerative diseases.

技术

Mobile Friendly

Other

常见问题

iRegene Therapeutics 在哪里?

iRegene Therapeutics 的总部位于 Wuhan, Hubei

iRegene Therapeutics 的电话号码是多少?

iRegene Therapeutics 的电话号码是 +86027-65522933

iRegene Therapeutics 的官方网站是什么?

iRegene Therapeutics 的公司官方网站是 http://www.iregene.com

iRegene Therapeutics 是做什么的?

iRegene Therapeutics focuses on new generation of chemical defined cell therapy and aims to play an essential role in curing “incurable”diseases, such as degenerative diseases.

iRegene Therapeutics 的业务有哪些?

retinal degenerative diseases,stem cell therapy,organoids,cardiology,regenerative medicine,neurology,chemai,chemicals,deep learning

iRegene Therapeutics 的年收入是多少?

iRegene Therapeutics 的收入是 0美元

iRegene Therapeutics 有多少员工?

iRegene Therapeutics 有 6 名员工

iRegene Therapeutics 属于哪个行业?

iRegene Therapeutics 从事以下行业: research

iRegene Therapeutics 使用什么技术?

iRegene Therapeutics 使用的一些流行技术包括: Mobile Friendly

如何联系 iRegene Therapeutics?

iRegene Therapeutics 联系信息: 电话号码:+86027-65522933, 网站:http://www.iregene.com, 邮箱:ema***@***.com

iRegene Therapeutics 的社交媒体链接是什么?

iRegene Therapeutics 领英:http://www.linkedin.com/company/iregene-therapeutics,fackbook:,twitte:

iRegene Therapeutics 是一家上市公司吗?

不是

iRegene Therapeutics 的最后一轮融资是什么时候?

iRegene Therapeutics在2020-07-01T00:00:00.000+00:00结束了最后一轮融资,金额达$。

谁投资 iRegene Therapeutics?

iRegene Therapeutics 有 1 家投资者,包括 。

管理层

Katy Huang

Financial Director

Emmanuel Montet

Executive Vice President Corporate Development & Strategy

员工

Meng Cai

Chief Medical Officer

Rain He

Business Development Associate

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google